ELI LILLY/ US5324571083 /
2024-02-02 4:00:28 PM | Chg. +7.50 | Volume | Bid4:00:26 PM | Ask4:00:27 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
613.00EUR | +1.24% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 671.97 bill.EUR | - | - |
GlobeNewswire
05-01
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-29
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
04-29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
04-26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
04-23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire
04-22
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
04-22
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
04-17
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GlobeNewswire
04-15
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...
GlobeNewswire
04-10
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atop...
Newsfile Corp
04-09
Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference